CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients

Majam, T; Sukasem, C; Reungwetwattana, T; Chansriwong, P; Atasilp, C; Trachu, N; Thamrongjirapat, T; Sukprasong, R; Meanwatthana, J

Meanwatthana, J (通讯作者)，Mahidol Univ, Fac Pharm, Dept Pharm, Bangkok, Thailand.

FRONTIERS IN PHARMACOLOGY, 2023; 14 ():

Abstract

Background: Osimertinib has shown greater efficacy than standard epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and fewer gra......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索